GI Multiplex qPCR assay
Introducing the GI Multiplex qPCR assays.
For the rapid measurement of 9 key GI targets.
Rapid diagnosis of gastrointestinal bacterial infections are critical as they can easily spread,
especially within the confines of healthcare facilities.
Our GI Multiplex qPCR assays cover a range of key gastrointestinal targets:
- C. difficile
- E. coli, Shigella & Enteroinvasive Escherichia coli (EIEC)
- Vibrio species
- Yersinia enterocolitica
- Escherichia coli O157
Our GI Multiplex qPCR assays are designed for speed, efficiency, simplicity, and affordability.
Here’s what sets our screening process apart:
Multiple Results, One Sample: Get up to nine different targets from a single sample, maximizing the information you can gather.
Multiplex or Individual Assays: Choose between running multiplex assays or individual tests, offering flexibility in your screening approach.
Rapid Processing: Tests can be processed within just 90 minutes, ensuring timely results.
Ambient Shipping: All test kit components are shipped at ambient temperature, making logistics simple.
Competitive Cost: We offer a cost-effective solution without compromising on quality or accuracy.
Training and Ongoing Support: Our team provides comprehensive training and continuous support to streamline your screening process.
Best in Class Accuracy: Trust in the accuracy of our tests, backed by extensive research and development.
Wide Compatibility: Our tests can be operated on a wide range of PCR platforms, making them adaptable to your facility’s needs.
Highlighting Other Targets: In case a patient tests negative for C. difficile, our assays can highlight other potential gastrointestinal issues.
*For general laboratory and research use only.
- Multiple results from one sample with up to 9 different targets.
- Multiplex or individual assays.
- Tests can be processed within 90 minutes.
- All test kit components shipped at ambient temperature.
- Competitive cost.
- Training and ongoing support.
- Best in class accuracy.
- Test can be operated on a wide range of PCR platforms.
- Highlights other targets if the patient tests negative for C. difficile.
Best In Class Performance
Under optimal PCR conditions, C. difficile_toxB detection kits have very high priming efficiencies of >95% and can detect less than 100 copies of target template.
About Katalyst Laboratories
Katalyst Laboratories is a leading distributor of diagnostics testing equipment, PCR assays and LFT tests.
Fully supported by training, support and regular bio surveillance updates.
Katalyst Laboratories stands at the forefront as a premier provider of intelligent healthcare solutions, spanning across hospital settings, residential environments, communities, surgical facilities, laboratories, and retail establishments.
We’d love to hear from you.
Please send a brief summary of your project and requirements and we’ll be in touch to discuss further.